| 货号 | 规格 | 价格 | 上海 | 北京 | 武汉 | 南京 | 购买数量 |
|---|---|---|---|---|---|---|---|
S81200-2mg |
≥99% | ￥210.80 | 货期：2-3天 | - | - | - |
|
S81200-5mg |
99.3% | ￥340.00 | 6 | - | - | - |
|
S81200-10mg |
99.3% | ￥530.40 | 4 | - | - | - |
|
S81200-25mg |
≥99% | ￥1088.00 | 货期：2-3天 | - | - | - |
|
S81200-50mg |
≥99% | ￥2040.00 | 货期：2-3天 | - | - | - |
|
S81200-100mg |
≥99% | ￥3100.00 | 货期：2-3天 | - | - | - |
|
PF-04418948 is an orally active, potent and selective prostaglandin EP2 receptor antagonist with an IC50 of 16 nM
| 产品描述： | PF-04418948 is an orally active, potent and selective prostaglandin EP2 receptor antagonist with an IC50 of 16 nM | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | Prostaglandin Receptor;ProstaglandinReceptor | ||||||||||||||||||||
| 体内研究： | PF-04418948 (oral gavage; 1, 3, and 10 mg/kg; once) attenuats the butaprost-induced cutaneous blood flow response | ||||||||||||||||||||
| 参考文献： | 1. af Forselles KJ, et al. In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist. Br J Pharmacol. 2011 Dec;164(7):1847-1856. 2. Birrell MA, et al. Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor. Br J Pharmacol. 2013 Jan;168(1):129-138. | ||||||||||||||||||||
| 溶解性： | DMSO : 130 mg/mL (317.53 mM; Need ultrasonic) | ||||||||||||||||||||
| 保存条件： | -20℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京